Unknown

Dataset Information

0

TGF-? signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE.


ABSTRACT: Effector Th1 cells perpetuate inflammatory damage in a number of autoimmune diseases, including MS and its animal model EAE. Recently, a self-regulatory mechanism was described in which effector Th1 cells produce the immunomodulatory cytokine IL-10 to dampen the inflammatory response in both normal and autoimmune inflammation. While the presence of TGF-? has been suggested to enhance and stabilize an IFN-?(+) IL-10(+) phenotype, the molecular mechanism is poorly understood. Additionally, in the context of adoptive transfer EAE, it is unclear whether IL-10 acts on the transferred Th1 cells or on endogenous host cells. In the present study, using myelin-specific TCR-Tg mice, we show that repetitive Ag stimulation of effector Th1 cells in the presence of TGF-? increases the population of IFN-?(+) IL-10(+) cells, which correlates with a decrease in EAE severity. Additionally, TGF-? signaling causes binding of Smad4 to the IL-10 promoter, providing molecular evidence for TGF-?-mediated IL-10 production from Th1 effector cells. Finally, this study demonstrates that IL-10 not only reduces encephalitogenic markers such as IFN-? and T-bet on Th1 effector cells expressing the IL-10R but also prevents recruitment of both transferred and host-derived inflammatory T cells. These data establish a regulatory mechanism by which highly activated Th1 effector cells modulate their pathogenicity through the induction of IL-10.

SUBMITTER: Huss DJ 

PROVIDER: S-EPMC3478765 | biostudies-literature | 2011 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE.

Huss David J DJ   Winger Ryan C RC   Cox Gina Mavrikis GM   Guerau-de-Arellano Mireia M   Yang Yuhong Y   Racke Michael K MK   Lovett-Racke Amy E AE  

European journal of immunology 20110830 10


Effector Th1 cells perpetuate inflammatory damage in a number of autoimmune diseases, including MS and its animal model EAE. Recently, a self-regulatory mechanism was described in which effector Th1 cells produce the immunomodulatory cytokine IL-10 to dampen the inflammatory response in both normal and autoimmune inflammation. While the presence of TGF-β has been suggested to enhance and stabilize an IFN-γ(+) IL-10(+) phenotype, the molecular mechanism is poorly understood. Additionally, in the  ...[more]

Similar Datasets

| S-EPMC2999006 | biostudies-literature
| S-EPMC5352159 | biostudies-literature
| S-EPMC5595963 | biostudies-literature
| S-EPMC3272378 | biostudies-literature
| S-EPMC6821034 | biostudies-other
| S-EPMC1440706 | biostudies-literature
| S-EPMC3517127 | biostudies-literature
| S-EPMC6340057 | biostudies-literature
| S-EPMC3490408 | biostudies-literature
| S-EPMC3753298 | biostudies-literature